" class="no-js "lang="en-US"> DiA Imaging Analysis Partners with Intelerad Medical Systems to Empower Echocardiography Labs with AI - Medtech Alert
Wednesday, April 10, 2024

DiA Imaging Analysis Partners with Intelerad Medical Systems to Empower Echocardiography Labs with AI

Intelerad Medical Systems™, a global leader in medical image management solutions, and DiA Imaging Analysis, a leading global provider of AI-based ultrasound software solutions, announced today a commercial partnership to offer DiA’s LVivo Seamless™ AI-based cardiac ultrasound software solution as part of Intelerad’s cardiac imaging solutions IntelePACS. This collaboration is aligned with Intelerad’s expansion of its enterprise imaging offerings in the cardiology space.

With over 130 million medical studies read each year by Intelerad, the company’s 2,000 global customers will now be able to obtain critical key measurement results for their echo studies. As a result, the efficiency of routine tasks will be vastly improved, as well as the effectiveness of workflow for echo reading cardiologists and other imaging specialists in the echo lab reading environment.

DiA’s LVivo Seamless™ AI-based software solution runs automatically ‘behind the scenes’ on echo lab servers, automatically selecting and analyzing the optimal cardiac ultrasound images and generating key clinical indications of left and right ventricle function. The results are immediately presented on the CPACS viewer as secondary-capture clips in-motion, saving time, reducing variability and optimizing echo lab workflow.

“This collaboration aligns with Intelerad’s ongoing expansion of its enterprise imaging offerings in the cardiology space and provides our customers the latest innovations in medical imaging AI,” said AJ Watson, Chief Product Officer of Intelerad.

This partnership follows Intelerad’s latest acquisitions of cardiac companies, including LUMEDXDigisonics and HeartIT, aimed at deepening the company’s ability to provide enterprise imaging and expand its expertise in the cardiovascular space.

“We’re excited to team up with Intelerad as they expand their footprint in the cardiac imaging space,” said Hila Goldman-Aslan, CEO and co-founder of DiA. “With Intelerad’s established presence in the medical imaging field, the value of our LVivo Seamless AI-based solution will now become more accessible to a wider base of echo labs.”

People In This Post

Companies In This Post

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more